ZWZipeng Wang

Zipeng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zipeng Wang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Cai Li

    Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    1 shared publication
  • Dandan Si

    SCIEX China, Beijing, China

    1 shared publication
  • De-Tao Yin

    Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    1 shared publication
  • Ji Zhang

    Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China; Henan Key Laboratory of Precision Clinical Pharmacy, Zhengzhou University, Zhengzhou, 450052, PR China

    1 shared publication
  • Jiashuo Lin

    School of Medicine, Zhengzhou University, Zhengzhou, China

    1 shared publication
  • Suhua Wang

    Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma

    by Zipeng Wang, Yiqin Yang, Yurong Xing, Dandan Si, Suhua Wang, Jiashuo Lin, Cai Li, Ji Zhang, Detao Yin

    Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy with a rapidly increasing incidence. The pathogenesis of PTC is unclear, but metabolic and lipidomic reprogramming may play a role in tumor growth. We applied ultra-performance liquid chromatography-tandem mass spectrometry to perform widely targeted metabolomics and lipidomics on plasma samples from 94 patients with PTC and 100 healthy controls. We identified 113 differential metabolites and 236 differential lipids, mainly involved in branched-chain amino acid metabolism, glutamate and glutamine metabolism, tricarboxylic acid cycle, and lipid metabolism. We also screened three potential metabolite biomarkers: sebacic acid, L-glutamine, and indole-3-carboxaldehyde. These biomarkers showed excellent diagnostic performance for PTC in both discovery and validation cohorts, with areas under the receiver operating characteristic curves of 0.994 and 0.925, respectively. Our findings reveal distinct metabolic and lipidomic features of PTC and provide novel targets for diagnosis and treatment.